General Statement of Disclosure:

CONSULTING FEES/HONORARIA: UpToDate(SIGNIFICANT), Imbria(MODEST) RESEARCH/RESEARCH GRANTS: Takeda Pharmaceuticals North America, Inc(MODEST), Novartis(NONE), Cytokinetics(SIGNIFICANT), iRhythm(NONE)

View Full Disclosure